• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Acute Venous Thromboembolism Risk Highest Within 60 Days After Discharge From the Hospital in Patients With Inflammatory Bowel Diseases.炎症性肠病患者出院后 60 天内的急性静脉血栓栓塞风险最高。
Clin Gastroenterol Hepatol. 2020 May;18(5):1133-1141.e3. doi: 10.1016/j.cgh.2019.07.028. Epub 2019 Jul 20.
2
Venous Thromboembolism Following Discharge from Hospital in Patients Admitted for Inflammatory Bowel Disease.炎症性肠病住院患者出院后发生的静脉血栓栓塞症
J Crohns Colitis. 2023 Jan 27;17(1):103-110. doi: 10.1093/ecco-jcc/jjac112.
3
Venous thromboembolism following colorectal resection.结直肠切除术后的静脉血栓栓塞
Colorectal Dis. 2017 Apr;19(4):385-394. doi: 10.1111/codi.13529.
4
Unawareness of thromboprophylaxis is associated with low venous thromboembolism occurrence in hospitalized patients with acute inflammatory bowel disease flare.住院的急性炎症性肠病发作患者对血栓预防的认识不足与静脉血栓栓塞症发生率低有关。
Minerva Med. 2020 Dec;111(6):560-565. doi: 10.23736/S0026-4806.20.06885-8. Epub 2020 Jul 28.
5
Risk of Venous Thromboembolism After Hospital Discharge in Patients With Inflammatory Bowel Disease: A Population-based Study.炎症性肠病患者出院后静脉血栓栓塞风险:一项基于人群的研究。
Inflamm Bowel Dis. 2020 Oct 23;26(11):1761-1768. doi: 10.1093/ibd/izaa002.
6
Inflammatory bowel disease and venous thromboembolism during pregnancy and the postpartum period.妊娠和产后期间的炎症性肠病和静脉血栓栓塞症。
J Thromb Haemost. 2017 Apr;15(4):702-708. doi: 10.1111/jth.13638. Epub 2017 Feb 24.
7
Not All Discharge Settings Are Created Equal: Thirty-Day Readmission Risk after Elective Colorectal Surgery.并非所有出院环境都相同:择期结直肠手术后 30 天再入院风险。
Dis Colon Rectum. 2020 Sep;63(9):1302-1309. doi: 10.1097/DCR.0000000000001727.
8
90-Day Specific Readmission for Clostridium difficile Infection After Hospitalization With an Inflammatory Bowel Disease Flare: Outcomes and Risk Factors.90 天内因炎症性肠病发作住院后艰难梭菌感染的特定再入院:结局和危险因素。
Inflamm Bowel Dis. 2021 Mar 15;27(4):530-537. doi: 10.1093/ibd/izaa224.
9
Surgery and the Subtype of Inflammatory Bowel Disease Impact the Risk of Venous Thromboembolism After Hospital Discharge.手术和炎症性肠病亚型会影响出院后静脉血栓栓塞的风险。
Dig Dis Sci. 2022 Jun;67(6):2471-2479. doi: 10.1007/s10620-021-07064-5. Epub 2021 Jun 10.
10
Inflammatory Bowel Disease: Predictors and Causes of Early and Late Hospital Readmissions.炎症性肠病:早晚期住院再入院的预测因素和原因。
Inflamm Bowel Dis. 2017 Oct;23(10):1832-1839. doi: 10.1097/MIB.0000000000001242.

引用本文的文献

1
Utility of rotational thrombo-elastometry as an objective measure of hypercoagulability in ulcerative colitis.旋转血栓弹力图作为溃疡性结肠炎高凝状态客观指标的效用
Indian J Gastroenterol. 2025 Apr 26. doi: 10.1007/s12664-025-01759-7.
2
Metabolic Disorders and Inflammatory Bowel Diseases.代谢紊乱与炎症性肠病
Gut Liver. 2025 May 15;19(3):307-317. doi: 10.5009/gnl240316. Epub 2025 Jan 8.
3
Acute Severe Ulcerative Colitis: An International Delphi Consensus on Clinical Trial Design and Endpoints.急性重症溃疡性结肠炎:关于临床试验设计与终点的国际德尔菲共识
Clin Gastroenterol Hepatol. 2024 Dec 15. doi: 10.1016/j.cgh.2024.10.029.
4
Controversies in Venous Thromboembolism Risk Assessment in Inflammatory Bowel Disease: A Narrative Review.炎症性肠病静脉血栓栓塞风险评估中的争议:一项叙述性综述
Diagnostics (Basel). 2024 Sep 24;14(19):2112. doi: 10.3390/diagnostics14192112.
5
Awareness and associated factors of venous thromboembolism in breast cancer surgical patients: a cross-sectional study.乳腺癌手术患者静脉血栓栓塞症的认知及相关因素:一项横断面研究。
BMC Cancer. 2024 May 21;24(1):610. doi: 10.1186/s12885-024-12231-8.
6
Genetic risk stratification of inflammatory bowel disease-associated venous thromboembolism: An Asian perspective.炎症性肠病相关静脉血栓栓塞的遗传风险分层:亚洲视角。
World J Gastroenterol. 2024 Mar 7;30(9):1250-1252. doi: 10.3748/wjg.v30.i9.1250.
7
Standard and Extended Thromboprophylaxis in Patients with Inflammatory Bowel Disease: A Literature Review.炎症性肠病患者的标准和延长血栓预防:文献综述
Euroasian J Hepatogastroenterol. 2023 Jul-Dec;13(2):133-141. doi: 10.5005/jp-journals-10018-1401.
8
Venous Thromboembolism in Patients with Inflammatory Bowel Disease.炎症性肠病患者的静脉血栓栓塞
J Clin Med. 2023 Dec 31;13(1):251. doi: 10.3390/jcm13010251.
9
Inflammatory Bowel Disease Therapy and Venous Thromboembolism.炎症性肠病治疗与静脉血栓栓塞症
Curr Treat Options Gastroenterol. 2020 Sep;18(3):462-475. doi: 10.1007/s11938-020-00304-z. Epub 2020 Aug 4.
10
Perioperative Management of Ulcerative Colitis: A Systematic Review.溃疡性结肠炎的围手术期处理:系统评价。
Dis Colon Rectum. 2022 Dec 1;65(S1):S5-S19. doi: 10.1097/DCR.0000000000002588.

本文引用的文献

1
A clinical predictive model for post-hospitalisation venous thromboembolism in patients with inflammatory bowel disease.炎症性肠病患者住院后静脉血栓栓塞症的临床预测模型。
Aliment Pharmacol Ther. 2019 Jun;49(12):1493-1501. doi: 10.1111/apt.15286. Epub 2019 May 8.
2
Past and Future Burden of Inflammatory Bowel Diseases Based on Modeling of Population-Based Data.基于基于人群数据的建模的炎症性肠病过去和未来负担。
Gastroenterology. 2019 Apr;156(5):1345-1353.e4. doi: 10.1053/j.gastro.2019.01.002. Epub 2019 Jan 10.
3
The risk of venous thromboembolism during and after hospitalisation in patients with inflammatory bowel disease activity.炎症性肠病活动期患者住院期间和出院后的静脉血栓栓塞风险。
Aliment Pharmacol Ther. 2018 Nov;48(10):1099-1108. doi: 10.1111/apt.15010. Epub 2018 Oct 8.
4
Extended Venous Thromboembolism Prophylaxis After Elective Surgery for IBD Patients: Nomogram-Based Risk Assessment and Prediction from Nationwide Cohort.择期手术治疗炎症性肠病患者的静脉血栓栓塞症延伸预防:基于列线图的全国性队列风险评估和预测。
Dis Colon Rectum. 2018 Oct;61(10):1170-1179. doi: 10.1097/DCR.0000000000001189.
5
Postpartum venous thromboembolism readmissions in the United States.美国产后静脉血栓栓塞再入院情况。
Am J Obstet Gynecol. 2018 Oct;219(4):401.e1-401.e14. doi: 10.1016/j.ajog.2018.07.001. Epub 2018 Jul 11.
6
Obesity Is Independently Associated With Higher Annual Burden and Costs of Hospitalization in Patients With Inflammatory Bowel Diseases.肥胖症与炎症性肠病患者的住院年负担和费用独立相关。
Clin Gastroenterol Hepatol. 2019 Mar;17(4):709-718.e7. doi: 10.1016/j.cgh.2018.07.004. Epub 2018 Sep 28.
7
Risk of thrombosis and mortality in inflammatory bowel disease.炎症性肠病的血栓形成和死亡风险。
Clin Transl Gastroenterol. 2018 Apr 3;9(4):142. doi: 10.1038/s41424-018-0013-8.
8
Thirty-Day Readmissions After Left Ventricular Assist Device Implantation in the United States: Insights From the Nationwide Readmissions Database.美国左心室辅助装置植入术后 30 天再入院情况:来自全国再入院数据库的分析。
Circ Heart Fail. 2018 Mar;11(3):e004628. doi: 10.1161/CIRCHEARTFAILURE.117.004628.
9
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.21 世纪全球炎症性肠病的发病率和流行率:基于人群的系统综述研究。
Lancet. 2017 Dec 23;390(10114):2769-2778. doi: 10.1016/S0140-6736(17)32448-0. Epub 2017 Oct 16.
10
Increased Rate of Venous Thromboembolism in Hospitalized Inflammatory Bowel Disease Patients with Clostridium Difficile Infection.住院炎症性肠病合并艰难梭菌感染患者的静脉血栓栓塞发生率增加。
Inflamm Bowel Dis. 2017 Oct;23(10):1847-1852. doi: 10.1097/MIB.0000000000001218.

炎症性肠病患者出院后 60 天内的急性静脉血栓栓塞风险最高。

Acute Venous Thromboembolism Risk Highest Within 60 Days After Discharge From the Hospital in Patients With Inflammatory Bowel Diseases.

机构信息

Division of Digestive and Liver Diseases, Department of Medicine, Columbia University Medical Center, New York, New York.

Department of Obstetrics and Gynecology, Columbia University Medical Center, New York, New York.

出版信息

Clin Gastroenterol Hepatol. 2020 May;18(5):1133-1141.e3. doi: 10.1016/j.cgh.2019.07.028. Epub 2019 Jul 20.

DOI:10.1016/j.cgh.2019.07.028
PMID:31336196
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6980437/
Abstract

BACKGROUND & AIMS: Patients with inflammatory bowel diseases (IBDs) have a high risk of venous thromboembolism (VTE). We assessed the timing and risk factors associated with readmission to the hospital for VTE among patients with IBD.

METHODS

We collected data from the Nationwide Readmissions Database on IBD index admissions resulting in readmission to the hospital for VTE within 60 days, from 2010 through 2014. We used univariable and multivariable regression to assess risk factors associated with VTE readmission with unadjusted risk ratio (RR) and adjusted RR (aRR) as measures of effect. Time to VTE readmission was assessed in 10-day intervals, for up to 90 days.

RESULTS

We identified 872,122 index admissions of patients with IBD; 1160 resulted in readmission with VTE. More than 90% of readmissions occurred within 60 days of discharge from the index admission. Factors associated with hospital readmission with VTE included prior VTE, longer length of hospital stay, comorbidities, having a flexible sigmoidoscopy or colonoscopy at index admission, and age older than 18 years. Additional risk factors included Clostridium difficile infection at index admission (aRR, 1.47; 95% CI, 1.17-1.85) and discharge to a skilled nursing facility or intermediate care facility (aRR, 1.39; 95% CI, 1.14-1.70) or discharge with home health services (aRR, 1.65; 95% CI, 1.41-1.94).

CONCLUSIONS

Among patients admitted to the hospital with IBD, most readmissions with VTE occur within 60 days of discharge. Readmission with VTE is associated with C difficile infection and discharge to a skilled nursing facility, intermediate care facility, or with home health services. Studies are needed to evaluate the potential benefit of extending VTE prophylaxis for patients admitted to the hospital with IBD for up to 2 months after discharge, to minimize risk.

摘要

背景与目的

炎症性肠病(IBD)患者有发生静脉血栓栓塞症(VTE)的高风险。本研究评估了 IBD 患者发生 VTE 再住院的时间和相关危险因素。

方法

我们从 2010 年至 2014 年的全国再入院数据库中收集了 IBD 索引入院患者的数据,这些患者因 VTE 再住院,时间在索引入院后 60 天内。我们使用单变量和多变量回归评估了 VTE 再住院的危险因素,未调整风险比(RR)和调整 RR(aRR)作为效应的衡量指标。VTE 再住院的时间评估为 10 天间隔,最长 90 天。

结果

我们确定了 872122 例 IBD 索引入院患者;其中 1160 例患者因 VTE 再住院。超过 90%的再住院发生在索引入院出院后 60 天内。与 VTE 再住院相关的因素包括既往 VTE、住院时间较长、合并症、索引入院时进行乙状结肠镜或结肠镜检查以及年龄大于 18 岁。其他危险因素包括索引入院时发生艰难梭菌感染(aRR,1.47;95%CI,1.17-1.85)和出院至专业护理机构或中级护理机构(aRR,1.39;95%CI,1.14-1.70)或出院时接受家庭健康服务(aRR,1.65;95%CI,1.41-1.94)。

结论

在因 IBD 住院的患者中,大多数 VTE 再住院发生在出院后 60 天内。VTE 再住院与艰难梭菌感染以及出院至专业护理机构、中级护理机构或接受家庭健康服务相关。需要开展研究评估对出院后长达 2 个月内的 IBD 住院患者延长 VTE 预防治疗的潜在获益,以降低风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e064/6980437/875434a75aa5/nihms-1535317-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e064/6980437/875434a75aa5/nihms-1535317-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e064/6980437/875434a75aa5/nihms-1535317-f0001.jpg